Figure 2: Effect of resveratrol treatment on ortho-tyrosine excretion in male IgAN patients. Changes of urinary ortho-tyrosine concentration (A) and urinary ortho-tyrosine/creatinine ratio (B) in male IgAN patients at Baseline, and after 6 week and 12 week of treatment with Resveratrol or Placebo.*, p<0.05.